Showing 35,541 - 35,560 results of 109,953 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( a ((nn decrease) OR (point decrease)) ))', query time: 1.44s Refine Results
  1. 35541

    Data Sheet 1_Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles.... by Ettore Silvagni (9576002)

    Published 2025
    “…Objective<p>The aim of this study was to comparatively assess the risk of cardiovascular events (CVEs) in rheumatoid arthritis (RA) patients treated with Janus kinase inhibitors (JAKis) or tumor necrosis factor inhibitors (TNFis) and to explore the interactions with patient profiles [including age, baseline cardiovascular (CV) risk, and frailty, which is a state of decreased physiological reserve, assessed using a validated frailty index (FI) for healthcare administrative databases (AHDs)].…”
  2. 35542

    Data Sheet 2_Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles.... by Ettore Silvagni (9576002)

    Published 2025
    “…Objective<p>The aim of this study was to comparatively assess the risk of cardiovascular events (CVEs) in rheumatoid arthritis (RA) patients treated with Janus kinase inhibitors (JAKis) or tumor necrosis factor inhibitors (TNFis) and to explore the interactions with patient profiles [including age, baseline cardiovascular (CV) risk, and frailty, which is a state of decreased physiological reserve, assessed using a validated frailty index (FI) for healthcare administrative databases (AHDs)].…”
  3. 35543
  4. 35544
  5. 35545
  6. 35546

    Supplementary Material for: Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The... by Marchant N.L. (10667460)

    Published 2021
    “…Trait-STAI decreased postintervention in both groups (CMBAS: –3.43 points; 95% CI –5.27 to –1.59; HSMP: –2.29 points; 95% CI –4.14 to –0.44) and reductions were maintained at follow-up. …”
  7. 35547
  8. 35548

    Image_2_Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Compo... by Fabiana Geraci (3873664)

    Published 2018
    “…In particular, the number of CSF-EVs increased in patients affected by MS during clinical relapse; this finding was associated with a decrease in the number of CD19<sup>+</sup>/CD200<sup>+</sup> (naïve B cells) EVs. …”
  9. 35549

    Image_3_Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Compo... by Fabiana Geraci (3873664)

    Published 2018
    “…In particular, the number of CSF-EVs increased in patients affected by MS during clinical relapse; this finding was associated with a decrease in the number of CD19<sup>+</sup>/CD200<sup>+</sup> (naïve B cells) EVs. …”
  10. 35550

    Table_1_Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Compo... by Fabiana Geraci (3873664)

    Published 2018
    “…In particular, the number of CSF-EVs increased in patients affected by MS during clinical relapse; this finding was associated with a decrease in the number of CD19<sup>+</sup>/CD200<sup>+</sup> (naïve B cells) EVs. …”
  11. 35551

    Image_1_Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Compo... by Fabiana Geraci (3873664)

    Published 2018
    “…In particular, the number of CSF-EVs increased in patients affected by MS during clinical relapse; this finding was associated with a decrease in the number of CD19<sup>+</sup>/CD200<sup>+</sup> (naïve B cells) EVs. …”
  12. 35552
  13. 35553
  14. 35554

    DataSheet_1_Spliceostatin C, a component of a microbial bioherbicide, is a potent phytotoxin that inhibits the spliceosome.docx by Joanna Bajsa-Hirschel (3902302)

    Published 2023
    “…In silico binding studies showed that SPC binds to a pocket between the SF3B3 and PF5A of the spliceosome.…”
  15. 35555
  16. 35556
  17. 35557
  18. 35558
  19. 35559

    Expression and secretion of ManB in <i>L</i>. <i>casei</i> MCJΔ1/pELSH-ManB. by Jinzhong Lin (189430)

    Published 2015
    “…<p>(<b>A</b>) ManB activity in the supernatant. ManB activity reached 8.85 U·ml<sup>-1</sup> during the exponential growth phase of <i>L</i>. …”
  20. 35560